IGC Stock Analysis: Buy, Sell, or Hold?
IGC - IGC Pharma, Inc.
$0.28
0.00 (0.14%)
▲
5d:
-6.22%
30d:
-6.22%
90d:
+0.25%
HOLD
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 26, 2026
9d
Get Alerted When IGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IGC is currently trading at $0.28, which is considered slightly low relative to its 30-day fair value range of $0.28 to $0.31.
Technical Outlook: Technically, IGC is in a uptrend. The price is currently testing key support at $0.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.25 (+1415.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IGC is in a uptrend. The price is currently testing key support at $0.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.25 (+1415.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.28 -
$0.31
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1415.7% below Wall St target ($4.25)
- CAUTION: Recommendation downgraded due to -6.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.31
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.31
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.12
Wall Street Target
$4.25
(+1415.7%)
Revenue Growth (YoY)
-3.9%
Share & Embed Analysis
Last updated: June 16, 2026 7:19 AM ET
Data refreshes hourly during market hours. Next update: 8:19 AM
Data refreshes hourly during market hours. Next update: 8:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IGC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
